Alnylam Pharmaceuticals Inc (ALNY)
246.80
-1.99
(-0.80%)
USD |
NASDAQ |
Nov 21, 16:00
247.11
+0.31
(+0.13%)
Pre-Market: 08:42
Alnylam Pharmaceuticals Shareholders Equity (Quarterly): 32.35M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 32.35M |
June 30, 2024 | -3.067M |
March 31, 2024 | -219.27M |
December 31, 2023 | -220.64M |
September 30, 2023 | -165.87M |
June 30, 2023 | -408.13M |
March 31, 2023 | -259.24M |
December 31, 2022 | -158.22M |
September 30, 2022 | -67.64M |
June 30, 2022 | 176.04M |
March 31, 2022 | 401.17M |
December 31, 2021 | 588.20M |
September 30, 2021 | 755.89M |
June 30, 2021 | 853.36M |
March 31, 2021 | 926.19M |
December 31, 2020 | 1.016B |
September 30, 2020 | 1.215B |
June 30, 2020 | 1.400B |
March 31, 2020 | 1.350B |
December 31, 2019 | 1.439B |
September 30, 2019 | 1.607B |
June 30, 2019 | 1.757B |
March 31, 2019 | 1.547B |
December 31, 2018 | 1.302B |
September 30, 2018 | 1.478B |
Date | Value |
---|---|
June 30, 2018 | 1.621B |
March 31, 2018 | 1.755B |
December 31, 2017 | 1.766B |
September 30, 2017 | 1.059B |
June 30, 2017 | 1.123B |
March 31, 2017 | 830.90M |
December 31, 2016 | 920.22M |
September 30, 2016 | 1.015B |
June 30, 2016 | 1.098B |
March 31, 2016 | 1.189B |
December 31, 2015 | 1.265B |
September 30, 2015 | 1.322B |
June 30, 2015 | 1.409B |
March 31, 2015 | 1.497B |
December 31, 2014 | 936.27M |
September 30, 2014 | 904.48M |
June 30, 2014 | 942.27M |
March 31, 2014 | 954.97M |
December 31, 2013 | 270.35M |
September 30, 2013 | 297.58M |
June 30, 2013 | 308.18M |
March 31, 2013 | 311.56M |
December 31, 2012 | 134.05M |
September 30, 2012 | 177.16M |
June 30, 2012 | 188.29M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-408.13M
Minimum
Jun 2023
1.439B
Maximum
Dec 2019
432.53M
Average
288.60M
Median
Shareholders Equity (Quarterly) Benchmarks
Pfizer Inc | 92.29B |
BridgeBio Pharma Inc | -1.230B |
Gilead Sciences Inc | 18.47B |
Johnson & Johnson | 70.16B |
Regeneron Pharmaceuticals Inc | 29.33B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 4.205B |
Total Liabilities (Quarterly) | 4.173B |
Debt to Equity Ratio | 31.64 |
Current Ratio | 2.749 |
Net Debt Paydown Yield | -0.00% |